RETA

Reata Pharmaceuticals, Inc. Class A Common Stock
RETA

Overview Fund Activity
Delisted

RETA was delisted on the 25th of September, 2023.

Back to rankings

214 hedge funds and large institutions have $3.27B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2020 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 78 increasing their positions, 71 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
214
Holders Change
-4
Holders Change %
-1.83%
% of All Funds
4.73%
Holding in Top 10
10
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-41.18%
% of All Funds
0.22%
New
33
Increased
78
Reduced
71
Closed
33
Calls
$129M
Puts
$56.6M
Net Calls
+$72M
Net Calls Change
-$45.9M

Top Buyers

1
Wellington Management Group
Wellington Management Group
Massachusetts
+$90.7M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$53M
3
TCM
TimesSquare Capital Management
New York
+$30.4M
4
PAMU
Pictet Asset Management (UK)
United Kingdom
+$16.4M
5
Ameriprise
Ameriprise
Minnesota
+$15.3M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$61.5M
2
CAM
Cormorant Asset Management
Massachusetts
-$47.5M
3
SPC
Slate Path Capital
New York
-$24.5M
4
Renaissance Technologies
Renaissance Technologies
New York
-$19.8M
5
BlackRock
BlackRock
New York
-$17.4M
Name Holding Trade Value Shares
Change 		Shares
Change %
Charles Schwab
26
Charles Schwab
California
$23.5M +$1.87M +12,978 +9%
CS
27
Candriam SCA
Luxembourg
$23.1M – – –
AAMU
28
Amundi Asset Management US
Massachusetts
$20M -$519K -3,593 -3%
Loomis, Sayles & Company
29
Loomis, Sayles & Company
Massachusetts
$19.3M +$2.59M +17,909 +15%
Bank of New York Mellon
30
Bank of New York Mellon
New York
$17.1M -$703K -4,868 -4%
Morgan Stanley
31
Morgan Stanley
New York
$16.6M +$8.6M +59,563 +108%
KP
32
Keel Point
Alabama
$16.6M +$194K +1,344 +1%
EA
33
Emerald Advisers
Pennsylvania
$16.5M +$1.79M +12,427 +12%
Renaissance Technologies
34
Renaissance Technologies
New York
$15.2M -$19.8M -137,000 -57%
RHJA
35
Rice Hall James & Associates
California
$14.6M -$494K -3,423 -3%
EMFAT
36
Emerald Mutual Fund Advisers Trust
Pennsylvania
$14.3M +$227K +1,570 +2%
PHS
37
PFM Health Sciences
California
$14.1M +$14.1M +97,864 New
Bank of America
38
Bank of America
North Carolina
$13.7M +$486K +3,366 +4%
BIA
39
Biondo Investment Advisors
Pennsylvania
$12.6M -$370K -2,563 -3%
LGM
40
Logos Global Management
California
$11.9M +$3.84M +26,592 +48%
ACM
41
Atika Capital Management
New York
$11.8M +$2.81M +19,500 +31%
Adage Capital Partners
42
Adage Capital Partners
Massachusetts
$11.5M -$4.76M -33,000 -29%
VOYA Investment Management
43
VOYA Investment Management
Georgia
$11.1M -$2.22M -15,380 -17%
Citadel Advisors
44
Citadel Advisors
Florida
$11M +$6.05M +41,951 +123%
PM
45
Prosight Management
Texas
$10.8M +$1.75M +12,100 +19%
KCM
46
Kennedy Capital Management
Missouri
$10.8M -$207K -1,431 -2%
SAM
47
Sectoral Asset Management
Quebec, Canada
$10.7M -$959K -6,641 -8%
GH
48
GAM Holding
Switzerland
$9.64M -$650K -4,500 -6%
Luther King Capital Management (LKCM)
49
Luther King Capital Management (LKCM)
Texas
$9.41M – – –
AIC
50
AWM Investment Company
New York
$8.66M -$2.17M -15,000 -20%
1
2
3 4 5